Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure-guided discovery strategies for Trop2-targeted small molecule inhibitors. | Bull Cancer | 2026 | 41667312 | PubTator, text mining | PubMed |
| The emerging role of TROP2 as a diagnostic and prognostic biomarker in bladder tumor. | Cancer Cell Int | 2026 | 41652619 | PubTator, text mining | PubMed |
| [Design and synthesis of molecularly imprinted polymers and their applications in medical diagnosis and biocatalysis]. | Se Pu | 2026 | 41641521 | PubTator, text mining | PubMed |
| Neoadjuvant chemoimmunotherapy in non-small cell lung cancer: evolving resectability criteria, biomarker-driven postoperative management, and emerging therapeutic strategies. | J Immunother Cancer | 2026 | 41638870 | PubTator, text mining | PubMed |
| Bispecific Antibodies in Breast Cancer Immunotherapy: Mechanisms, Advances, and Translational Challenges. | Target Oncol | 2026 | 41637006 | PubTator, text mining | PubMed |
| Tiny tools closing the gap: nanobodies in research and therapy. | Function (Oxf) | 2026 | 41627946 | PubTator, text mining | PubMed |
| A shark VNAR-IL-15 fusion protein that suppresses TROP2+ tumor growth. | Int J Biol Macromol | 2026 | 41621509 | PubTator, text mining | PubMed |
| A preliminary model of an oral dysplastic lesion on a chip. | Tissue Cell | 2026 | 41621185 | PubTator, text mining | PubMed |
| Tumor-associated macrophages display differential protein cargo sorting in extracellular vesicles associated with poor survival in ovarian cancer. | Mol Med | 2026 | 41618130 | PubTator, text mining | PubMed |
| Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With Nivolumab. | Anticancer Res | 2026 | 41617423 | PubTator, text mining | PubMed |
| Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy. | PLoS Med | 2026 | 41616036 | PubTator, text mining | PubMed |
| A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer Therapy. | Oncol Res | 2026 | 41613789 | PubTator, text mining | PubMed |
| The role and prospects of the Fudan classification in precision medicine for triple-negative breast cancer. | Cancer Genet | 2026 | 41604874 | PubTator, text mining | PubMed |
| Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody-Drug conjugates. | Cancer Treat Rev | 2026 | 41604872 | PubTator, text mining | PubMed |
| Treatment options and considerations for acquired resistance in EGFR mutation-positive non-small-cell lung cancer. | ESMO Open | 2026 | 41604816 | PubTator, text mining | PubMed |
| [From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma]. | Urologie | 2026 | 41603912 | PubTator, text mining | PubMed |
| In vivo engineering of CAR-T cells: delivery strategies and clinical translation. | Biomark Res | 2026 | 41593732 | PubTator, text mining | PubMed |
| Biopsy RNA-seq captures TROP-2-linked migration and clonal resistance to forecast aggressiveness in metastatic melanoma. | J Exp Clin Cancer Res | 2026 | 41593664 | PubTator, text mining | PubMed |
| Trop-2.2-Directed Radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a Pancreatic Cancer Model. | Clin Cancer Res | 2026 | 41591978 | PubTator, text mining | PubMed |
| Advances in Screening, Immunotherapy, Targeted Agents, and Precision Surgery in Cervical Cancer: A Comprehensive Clinical Review (2018-2025). | Curr Oncol | 2026 | 41590369 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=16